Approximately 5% of the world-wide population is affected by autoimmune diseases.
Overall, autoimmune diseases are still difficult to treat, impose a high burden on patients …

Epidermolysis bullosa acquisita (EBA) is an orphan autoimmune disease. Patients with EBA
suffer from chronic inflammation as well as blistering and scarring of the skin and mucous …

Autoimmune blistering diseases are characterized by autoantibodies against structural
adhesion proteins of the skin and mucous membranes. Extensive characterization of their …

Introduction: Epidermolysis bullosa acquisita (EBA) is a rare autoimmune blistering disease
of skin and mucous membranes. EBA is caused by autoantibodies against type VII collagen …

Epidermolysis bullosa acquisita (EBA) is a prototypic organ-specific autoimmune disease
induced by autoantibodies to type VII collagen causing mucocutaneous blisters. In the …

Epidermolysis bullosa acquisita (EBA) is a chronic mucocutaneous autoimmune skin
blistering disease. The pathogenic relevance of autoantibodies targeting type VII collagen …

Background: In major depressive disorder (MDD), findings include hyperstable regulation of
brain arousal measured by electroencephalography (EEG) vigilance analysis and …

Epidermolysis bullosa acquisita (EBA) is a rare autoimmune bullous disease (AIBD).
However, higher EBA incidence and predisposing genetic factor (s) involving an HLA …

IgG antibodies have one conserved N‐glycosylation site at Asn 297 in each of their constant
heavy chain regions. These Fc glycans influence the overall structure and pro‐or anti …

Background Plasmacytosis (ie, an expansion of plasma cell populations to much greater
than the homeostatic level) occurs in the context of various immune disorders and plasma …